TNP-470/minocycline/cytotoxic therapy: A systems approach to cancer therapy
- 1 December 1996
- journal article
- review article
- Published by Elsevier in European Journal Of Cancer
- Vol. 32 (14) , 2461-2466
- https://doi.org/10.1016/s0959-8049(96)00380-2
Abstract
No abstract availableThis publication has 28 references indexed in Scilit:
- Potent anti-angiogenic action of AGM-1470: comparison to the fumagillin parentPublished by Elsevier ,2004
- Antiangiogenic agents can increase tumor oxygenation and response to radiation therapyRadiation Oncology Investigations, 1994
- Definition and manipulation of tumor oxygenationRadiation Oncology Investigations, 1994
- The influence of angiogenesis inhibitor AGM‐1470 on immune system status and tumor growth in vitroInternational Journal of Cancer, 1993
- Analysis of experimental antiangiogenic therapyJournal of Pediatric Surgery, 1993
- Synthetic analogues of fumagillin that inhibit angiogenesis and suppress tumour growthNature, 1990
- Tumors: Wounds That Do Not HealNew England Journal of Medicine, 1986
- Reassessment of Criteria for the Selection of Perfluorochemicals for Second‐Generation Blood Substitutes: Analysis of Structure/Property RelationshipsArtificial Organs, 1984
- The Treatment of Amebiasis with FumagillinScience, 1952
- THE DISTRIBUTION OF SECONDARY GROWTHS IN CANCER OF THE BREAST.The Lancet, 1889